Lymphocyte‐C‐reactive protein ratio as a novel prognostic index in intrahepatic cholangiocarcinoma: A multicentre cohort studyLianghe Lu, Yong‐Fa Zhang, Chong Zhong et al.|Liver International|2020Cited by 62
Comparison of the Prognostic Value of Inflammation-Based Scores in Patients with Hepatocellular Carcinoma After Anti-PD-1 TherapyJie Mei, Rong Guo, Xuqi Sun et al.|Journal of Inflammation Research|2021Cited by 49
Neoadjuvant transarterial infusion chemotherapy with FOLFOX could improve outcomes of resectable BCLC stage A/B hepatocellular carcinoma patients beyond Milan criteria: An interim analysis of a multi-center, phase 3, randomized, controlled clinical trial.Shaohua Li, Rong Guo, Chong Zhong et al.|Journal of Clinical Oncology|2021Cited by 30
Long noncoding RNA TINCR facilitates hepatocellular carcinoma progression and dampens chemosensitivity to oxaliplatin by regulating the miR-195-3p/ST6GAL1/NF-κB pathwayJie Mei, Rong Guo, Zhiwei Ye et al.|Journal of Experimental & Clinical Cancer Research|2022Cited by 30
Real-world outcomes of patients with advanced intrahepatic cholangiocarcinoma treated with programmed cell death protein-1-targeted immunotherapyMin Deng, Rong Guo, Shaohua Li et al.|Annals of Medicine|2022Cited by 22